Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Nov 25, 2016 $1.49 $1.68 $1.49 $1.65 971 538
Nov 23, 2016 $1.49 $1.59 $1.43 $1.49 2 039 661
Nov 22, 2016 $2.24 $2.24 $2.14 $2.16 170 951
Nov 21, 2016 $2.38 $2.38 $2.11 $2.28 232 107
Nov 18, 2016 $2.59 $2.60 $2.30 $2.40 177 844
Nov 17, 2016 $2.78 $2.90 $2.48 $2.61 361 669
Nov 16, 2016 $2.55 $2.82 $2.49 $2.65 832 682
Nov 15, 2016 $1.94 $2.63 $1.93 $2.35 1 232 367
Nov 14, 2016 $1.91 $1.95 $1.77 $1.86 74 737
Nov 11, 2016 $1.90 $2.00 $1.78 $1.90 57 307
Nov 10, 2016 $1.89 $2.00 $1.69 $1.77 190 496
Nov 09, 2016 $1.69 $1.90 $1.69 $1.86 50 725
Nov 08, 2016 $1.65 $1.70 $1.65 $1.69 63 906
Nov 07, 2016 $1.66 $1.69 $1.50 $1.63 147 700
Nov 04, 2016 $1.63 $1.68 $1.62 $1.65 40 000
Nov 03, 2016 $1.73 $1.80 $1.63 $1.63 22 300
Nov 02, 2016 $1.74 $1.86 $1.70 $1.70 60 000
Nov 01, 2016 $1.84 $1.88 $1.72 $1.75 34 800
Oct 31, 2016 $1.74 $1.97 $1.65 $1.85 172 600
Oct 28, 2016 $1.84 $1.92 $1.72 $1.74 61 200
Oct 27, 2016 $1.84 $1.89 $1.70 $1.83 92 400
Oct 26, 2016 $1.90 $1.94 $1.80 $1.81 49 500
Oct 25, 2016 $1.91 $2.00 $1.81 $1.89 88 600
Oct 24, 2016 $2.04 $2.10 $1.68 $1.83 221 600
Oct 21, 2016 $2.01 $2.10 $2.01 $2.04 68 200
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT